Sampre Nutritions Limited has issued a regulatory intimation to BSE Limited regarding a scheduled meeting of its Board of Directors. The meeting is set to be held on Friday, 29 May 2026.
The sole agenda for the board meeting is to consider and approve the company's audited standalone financial results and audited consolidated financial results for the quarter and financial year ended 31 March 2026.
This intimation is made in compliance with the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, specifically under Regulation 29, and other applicable regulations.
The document was digitally signed by Brahma Gurbani, the Managing Director of the company (DIN: 00318180), on 26 May 2026 at 17:15:41 IST.